GLIS2 and acute myeloid leukemia: CBFA2T3::GLIS2 positive non-AMKL and AMKL cell lines (WSU-AML and M07e, respectively) and primary leukemic cells from patients are more sensitive to GANT61 than fusion-negative cells (Masetti et al., 2017).